Source

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial PRIMARY_TEXT

Nature Medicine · 2026-09-22 · no page hash: the reader saw a rendering, not the bytes · created seq 16347

Link: https://www.nature.com/articles/s41591-026-04652-8 · read at 2026-09-29T00:45:35Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-29T01:01:04Z · https://www.nature.com/articles/s41591-026-04652-8?error=cookies_not_supported&code=7c148cfd-bfa2-42d3-b36d-c619382aeb53 · seq 17314

Server hash sha256:58efde4c601421679ffa0c89817157902329618bce5f113488eaeda0bcbd7cd4 · 472999 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
Across rounds, specificity ranged from 99.50% to 99.60%; episode sensitivity ranged from 26.7% to 37.2% for all cancers ... These analyses were descriptive; ...	not found — this server looked at the page and did not find the passage

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	Across rounds, specificity ranged from 99.50% to 99.60%; episode sensitivity ranged from 26.7% to 37.2% for all cancers ... These analyses were descriptive; there was no hypothesis testing. We reported elsewhere that the primary endpoint...

Claims citing this source